
August 21, 2019 Research and Development, Sales and Marketing AbbVie, NICE, Skyrizi, pharma

August 21, 2019 Research and Development Mylan, Teva, allergies, children, epipen, pharma

August 21, 2019 Research and Development AstraZeneca, Cancer, Imfinzi, lung cancer, pharma

August 21, 2019 Research and Development Chugai, Hemlibra, Roche, haemophilia, pharma

August 21, 2019 Research and Development AveXis, FDA, Novartis, Zolgensma, data scandal, pharma, sma

August 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Genomenon, Rare Genomics Institute, pharma, rare disease

August 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Air pollution, CAR-T therapy, HIV, Kymriah, Medicare, Novartis, Yescarta, Zolgensma

August 15, 2019 Research and Development Regeneron, evinacumab, pharma, rare disease

August 15, 2019 Research and Development Eli Lilly, Taltz, Tremfya, pharma, psoriasis

August 15, 2019 Research and Development FDA, TB, US, pharma, pretomanid, tuberculosis

August 14, 2019 Research and Development AstraZeneca, Cancer, MSD, lynparza, ovarian cancer, pharma

August 14, 2019 Research and Development, Sales and Marketing Europe, Janssen, chronic lymphocytic leukaemia, imbruvica, pharma

August 14, 2019 Research and Development Addison's disease, Aspen Pharmacare, CMA, NHS, pharma

August 14, 2019 Research and Development Air pollution, COPD, lung disease, pharma emphysema, public health

August 13, 2019 Research and Development AveXis, Chuck Grassley, Novartis, Zolgensma, sfc